European Pharmaceutical Review

NOVEMBER 7, 2024

A report by Azoth Analytics expects that globally, the single-use technology rocking bioreactors market will grow at a compound annual growth rate (CAGR) of 3.9 percent between 2025 and 2030. The report noted that last year, the cell culture sector held approximately 60 percent of the single-use technology rocking bioreactors market.

Compounding 52

Compounding Vaccines 52

European Pharmaceutical Review

JUNE 27, 2022

The Kigali Summit on Malaria and NTDs , hosted by His Excellency (HE) Paul Kagame, President of the Republic of Rwanda, on Thursday 23 June 2022, gathered world leaders to commit to ending these devastating diseases by the end of 2030. Did you know, 1.7 LXE408 is currently entering Phase II clinical development.

Vaccines 110

Vaccines Communication Documentation Compounding 110

Pharmaceutical Technology

MAY 18, 2023

The World Health Organization (WHO) 2021 roadmap outlines plans to eradicate 20 listed diseases, which include leprosy, scabies and mycetoma, by 2030. Neglected tropical diseases are a major global health concern, affecting over 1.7 billion people, many of whom live in the poorest and most vulnerable communities.

Vaccines 52

Vaccines Compounding FDA 52

ISPE

SEPTEMBER 11, 2023

Examples include platforms as small as autonomous units placed within a facility and mobile production trailers for compounding to platforms as large as a prefabricated, self-contained GMP facility. Worldwide Modular Facilities in Pharmaceutical and Biotechnology Industry to 2030 - Impact Analysis of COVID-19.” 13 July 2021.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

Hospital Pharmacy Europe

JANUARY 19, 2023

Worldwide, more than 700,000 people die by suicide annually and the WHO has set a target to reduce suicides by one third by 2030. The problems for community pharmacists can be compounded by the lack of suitable referral pathways and the fact that patients do not always understand why the pharmacist is asking questions.

Community Pharmacies 98

Community Pharmacies Hospitals Communication Medical Schools 98

PharmaShots

APRIL 3, 2023

of the newly combined company The combined companies’ focus is to advance Elicio’s lymph node-targeting amphiphile technology to develop immunotherapies & also focus on ELI-002, a therapeutic cancer vaccine targeting mKRAS-driven tumors is currently being evaluated in the P-I trial (AMPLIFY-201) for PDAC and CRC.

FDA 40

FDA Compounding Hospitals Vaccines 40

Pharmaceutical Technology

MAY 22, 2023

The possibility of additional funding comes at a time replete with investor uncertainty as a result of ongoing financial instability in the market, which has been compounded by the collapse of Silicon Valley Bank (SVB) and Credit Suisse. billion) by 2030. The UK government also has its own plans for funding research. billion ($18.2

Vaccines 111

Vaccines Compounding Communication 111